Inventor · disambiguated record
Samuel V. Agresta
Also filed as: AGRESTA SAMUEL · AGRESTA SAMUEL V
14 granted patents·17 pending applications·69 citations·filing 2010–2025
91Inventor score
Files withAGIOS PHARMACEUTICALS INC16GENENTECH INC4SERVIER PHARMACEUTICALS LLC4FOGHORN THERAPEUTICS INC3CELGENE CORP2
Top patents by PatentIndex Score
31 records- 0193US9738625B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 22, 2017·16 cites·20 claims
- 0293US9694013B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·14 cites·17 claims
- 0392US9511155B2Compositions and methods for non-invasive imagingMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Dec 6, 2016·10 cites·19 claims
- 0490US10730854B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Aug 4, 2020·3 cites·72 claims
- 0588US11419859B2Combination therapy for treating malignanciesSERVIER PHARMACEUTICALS LLC·Filed 2016·Granted Aug 23, 2022·5 cites·22 claims
- 0688US10905692B2Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 2, 2021·3 cites·22 claims
- 0788US9889137B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Feb 13, 2018·6 cites·8 claims
- 0886US2024390354A1Therapy for treating malignanciesSERVIER PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0985US10093654B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·3 cites·70 claims
- 1082US2024132474A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1182US2023277514A1Therapy for treating malignanciesSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1280US10695352B2Combination therapy for treating malignanciesCELGENE CORP·Filed 2016·Granted Jun 30, 2020·4 cites·15 claims
- 1380US10105369B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 23, 2018·2 cites·24 claims
- 1476US10980788B2Therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·0 cites·19 claims
- 1574US10653710B2Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 19, 2020·2 cites·20 claims
- 1674US2025387386A1Methods of using pyruvate kinase activatorsAGIOS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1773US2021205281A1Therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1870US2021155603A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1967US11234976B2Methods of using pyruvate kinase activatorsAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 1, 2022·1 cites·16 claims
- 2066US2020069694A1Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1GENENTECH INC·Filed 2019·Application pending·0 cites
- 2164US2022211697A1Methods of using pyruvate kinase activatorsAGIOS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2264US2025241931A1Methods of treating a subject having clinically significant signs and symptoms associated with blood cell differentiationFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2364US2025325553A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2462US2021386749A1Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2561US2025339441A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2660US9968694B2Compositions and methods for non-invasive imagingMERRIMACK PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·20 claims
- 2755US2021100805A1Combination therapy for treating malignanciesCELGENE CORP·Filed 2020·Application pending·0 cites
- 2852US2020405737A1Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2952US2015265723A1Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1GENENTECH INC·Filed 2015·Application pending·0 cites
- 3048US2017202973A1Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1GENENTECH INC·Filed 2017·Application pending·0 cites
- 3145US2011165155A1Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1GENENTECH INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel V. Agresta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →